Learn about Orforglipron medication Orforglipron is an investigational medication currently being studied for weight loss and type 2 diabetes
Study 2 ( N = 706) examined stigma directed at people who regain weight after discontinuing GLP-1s, and the target was described as either: having regained weight after discontinuing a GLP-1, having regained weight after discontinuing a diet and exercise plan, not having lost weight, or having maintained weight loss
Supervision is the safeguard, which is why we monitor rather than prescribe once and walk away
You agree that MTA, and all other persons or entities involved in the operation of Services provided through this Site, has the right to monitor, retrieve, store and use confidential health information in connection with the operation of such Services, and are acting on your behalf in transmitting confidential health information